Introduction

S
elf-renewable human (h) pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced PSCs (iPSCs), serve as a potential unlimited ex vivo source of human cardiomyocytes (CMs) for cell-based therapies, disease modeling, and other applications such as drug discovery and cardiotoxicity screening. Recent advances in directed cardiac differentiation protocols [1] [2] [3] [4] [5] [6] [7] have enabled the derivation of hESC/iPSC-CMs with yields several orders of magnitude higher than those of traditional methods, such as ''spontaneous'' embryoid body (EB) formation [8, 9] and endodermal coculture [10, 11] . Using defined serum-free media in combination with cocktails of such growth factors required for normal cardiogenesis as bone morphogenetic proteins (BMPs), activin-A, Wnt agonists and antagonists, fibroblast growth factor 2 (FGF2), and vascular endothelial growth factor (VEGF), and Dickkopf-related protein (DKK), these protocols can generate *40%-90% cardiac troponin T (cTnT) + CMs with a final yield ranging from 1 to 20 CMs per starting undifferentiated hPSC [2] [3] [4] 12, 13] . However, they often require PSC-line-dependent titrations of multiple parameters (eg, BMP4 and activin-A concentrations) [1, 14, 15] and other specific needs (eg, sandwich matrix) [2] , particularly for hiPSC lines that tend to be more variable [16] . Further, while relatively effective for generating cardiac cells, the resultant populations are undefined for chamber specificity [4, 5, 13] or heterogeneous containing mixtures of atrial, ventricular (V), and pacemaker derivatives [17] . Here we report a highly cost-effective and reproducibly efficient system for deriving hPSC-ventricular cardiomyocytes (VCMs) from all the five hESC (HES2, H7, and H9) and iPSC (reprogrammed from adult peripheral blood CD34
+ cells using non-integrating episomal vectors) lines tested.
Materials and Methods
hiPSC and ESC culture hiPSC lines were derived from adult peripheral blood CD34
+ cells using the non-integrated episomal vectors pCXLEhOCT3/4-shp53, pCXLE-hSK, and pCXLE-hUL [18] . Briefly, CD34
+ cells were purified (> 95% purity) from anonymous donors and expanded in StemSpanÔ H3000 (Stemcell Technologies) with the cytokine cocktail CC100 (Stemcell Technologies) for 3 days. Cells were nucleofected with the episomal vectors using the Human CD34 Cell NucleofectorÔ kit (Amaxa) according to the manufacturer's protocol. After 72 h, cells were transferred to MatrigelÔ (BD Biosciences)-coated plates in mTeSRÔ1 medium (STEMCELL Technologies). Morphological changes were observed a few days later. Colonies resembling hPSCs typically started to appear on day 7, and were picked on day 13 after nucleofection. H7 (WiCell), H9 DF , (a kind gift from Dr. Joseph Wu), HES2 (ESI) (passages 35-55) hESC and hiPSC lines were maintained in feeder-and serum-free condition in mTeSR1 medium on Matrigel at 37°C in 5% CO 2 in a humidified normoxic environment.
hiPSC validation
To characterize hiPSC clones, cultured cells were fixed by 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, followed by permeabilization by 0.1% Triton X-100 for 15 min, and washing with PBS for three times. The fixed samples were stained with anti-OCT4, SSEA-4, and Tra-1-81 for 2 h at room temperature (RT) (Supplementary Table S1 ; Supplementary Data are available online at www.liebertpub.com/scd) and then with flurochrome-conjugated goat anti-rabbit or anti-mouse secondary antibodies for 1 h. To test for pluripotency, hiPSCs were differentiated to form EBs in DMEM/F12 (Life Technologies) with 20% Knockout Serum Replacement (Life Technologies), 2 mM nonessential amino acids, 2 mM l-glutamine, and 0.1 mM b-mercaptoethanol. At day 15, EBs were stained for markers of the three germ layers (ie, Tuji, SMA, and AFP). For teratoma formation, 1 · 10 6 iPSCs were injected subcutaneously into NOD/SCID immunodeficient mice. Teratomas were harvested and stained 7-9 weeks after injection for H&E staining. Karyotyping was done according to a published protocol [19] .
Direct ventricular cardiomyocyte differentiation
Undifferentiated hPSCs were digested into smaller clusters using Dispase (STEMCELL Technologies) and seeded onto Matrigel-coated plates at *3 · 10 5 cells/10 cm 2 in mTeSR1 medium for 4 days until they were *80%-90% confluence on D0 (Fig. 1) . To initiate cardiac differentiation, hPSCs were digested into single-cell suspensions in ultralow-attachment six-well plates (Corning) using Accutase (Invitrogen) and cultured in mTeSR1 medium with Matrigel (40 mg/mL) with BMP4 (1 ng/mL; Invitrogen) and Rho kinase inhibitor (ROCK) (10 mM; R&D) under a hypoxic condition with 5% O 2 . Twenty-four hours later, the culture was washed and replaced in StemPro34 SFM (Invitrogen) with ascorbic acid (AA, 50 mg/mL; Sigma), 2 mM Gluta-MAX-1 (Invitrogen), BMP4 (10 ng/mL), and human recombinant activin-A (10 ng/mL; Invitrogen) for 3 days. On day 4, IWR-1, a Wnt inhibitor (5 mM; Enzo Life Sciences), was added. Cardiac mesodermal cells developed into functional contracting clusters could be detected as early as day 8. On day 8, cells were transferred to a normoxic environment and maintained in StemPro34 SFM + AA medium for further characterization. In some cases, the cardiac mixtures (30-50 days old) were transduced with the recombinant lentivirus (LV)-MLC2v-Tdtomato-T2A-Zeo. MLC2v-positive cells were selected using the antibiotic Zeocin.
Immunostaining for CMs and flow cytometry analysis
For immunostaining of cardiac cells, beating clusters (between 16 and 35 days of differentiation) were digested into single cells and immunostained with anti-cTnT, sarcomeric, aactinin, connexin 43, COXIV, myosin heavy chain (MF20), two isoforms of myosin light chain 2, MLC2a, and MLC2v antibodies listed in Supplementary Table S1 . Primary antibodies were diluted in PBS with 1% BSA and incubated at RT for 2 h. Alexa Fluor (AF)488-conjugated goat anti-mouse IgG or AF555 anti-mouse IgG (Invitrogen) were used as secondary antibodies and stained for 1 h at RT. Coverslips were mounted onto glass slides in Prolong Gold mounting medium with DAPI (Invitrogen) and samples were imaged on LSM Carl Zeiss 510 Meta (Carl Zeiss) or Nikon Eclipse TiS microscope. For flow cytometry, cells were digested and resuspended in PBS with 2% FBS. To stain for intracellular markers, cells were fixed, permeabilized, and stained with antibodies against various cardiac markers. To measure cardiac differentiation, percentages of CMs were estimated based on the % of cTnT-positive cells at differentiation days [16] [17] [18] .
Metabolic stress and mitochondrial membrane potential
Mitochondrial membrane potential in HES2-VCMs was measured with the potential-sensitive dye JC-1 (Invitrogen). LV-MLC2v-Tdtomato-T2A-Zeo-transduced and Zeo-selected HES2-VCMs (30-50 days old) were incubated at 37°C with 0.5 mM JC-1 in serum-free DMEM for 15 min. To simulate metabolic oxidative stress, HES2-VCMs were treated with hydrogen peroxide (H 2 O 2 ; 100 mM) for 30 min at 37°C after which JC-1 orange and green fluorescence intensity was measured for mitochondrial membrane potential with LSM Carl Zeiss 510 Meta.
Mitochondrial volume estimation
HES2-VCMs were incubated at 37°C with 0.1 mM MitoTracker Ò Deep Red and 0.1 mM Cell Tracker (Invitrogen) for 30 min for mitochondrial volume estimation. Stack images of mitochondria and cytoplasm were obtained with LSM Carl Zeiss 510 Meta. Three-dimensional images of HES2-VCMs were constructed and mitochondrial volume was estimated as % of total cell volume with the imaging analysis software Imaris (Bitplane).
RNA extraction, cDNA synthesis, and gene expression analysis by real-time PCR Total RNA was extracted from samples using RNeasy Mini Kit (Qiagen) following DNase I (Promega) treatment for the removal of potential contamination of genomic DNA. cDNA was prepared using the QuantiTect Rev. Transcription Kit (Qiagen) following the manufacturer's protocol. Gene expression was quantified using StepOnePlusÔ Real-Time PCR system (Applied Biosystems). PCR amplification was carried out in 96-well optical plates consisting of 100 ng of cDNA template, 5 pmol of forward and reverse primers, and 1X KAPA SYBR Ò Fast qPCR Master Mix (KAPA Biosystems). The reactions were incubated at 95°C for 3 min, and followed by 40 cycles of 95°C for 3 s, and 60°C for 20 s. GAPDH was used as internal control to normalize loading and all reactions were performed in triplicate. Primers are listed in Supplementary Table S2 .
Electrophysiological characterization
Electrophysiological experiments were performed using the whole-cell patch-clamp technique as previously described [20] [21] [22] . To profile chamber-specific subtypes of our hPSCderived CMs (hPSC-CMs), action potentials (APs) of the myocytes were randomly probed at 37°C with the patchclamp technique using an EPC-10 amplifier and Pulse software (Heka Elektronik), with the current-clamp mode (0.1-0.5 nA for 1-5 ms) under the whole-cell configuration applied. The hPSC-CMs were categorized into nodal, atrial, or ventricular like according to the standard AP parameters as we and others previously described [17, 20, 21] . Voltage-clamp recordings of ionic currents were performed using an automated parallel patch-clamp system (PatchXpress 7000A; Molecular Devices) using standard electrophysiological and 
Ca 2 + imaging
The intracellular Ca 2 + ([Ca 2 + ] i ) transients were imaged by a spinning disc laser confocal microscope (PerkinElmer) on hPSC-CMs loaded with 1.5 mM X-Rhod-1 (Invitrogen) as previously described [21] . After dye loading, experiments were performed at 37°C in Tyrode's solution containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.25 mM CaCl 2 , 10 mM HEPES, and 10 mM d-glucose at pH 7.4. Electric pulses (40 ms pulse duration; 40 V/cm; 1 Hz) generated by a field generator were continuously applied to pace electrically induced Ca 
Statistical analysis
Data are presented as means -SEM. Student's t-test or ANOVA was used to measure statistical significance. P < 0.05 is considered significant.
Results
Highly efficient ventricular specification of hESCs
We initially focused on HES2, the same hESC line that Keller et al. employed for developing their original directed differentiation protocols [1, 3, 25] . Our modified method for ventricular specification is schematically summarized in Figure 1A . To start, undifferentiated cells were seeded as 30,000 cells/cm 2 for expansion in mTeSR1 medium for 4 days. On day 0, hPSCs were digested into single cells and cultured in suspension in mTeSR1 medium with Matrigel along with BMP4 (1 ng/mL) and ROCK (10 mM) to induce differentiation. After 24 h, the media was changed to StemPro34 SFM with BMP4 (10 ng/mL), activin-A (10 ng/ mL), and AA (50 mg/mL) to induce the formation of cardiogenic mesodermal EBs. As the last step, on day 4 when nicely compact rounded aggregates could be observed, IWR-1 (5 mM) was added to suppress Wnt signaling (Fig.  1B) . As early as day 8, > 70% of hEBs from 30 out of 30 independent differentiation reactions became spontaneously contracting (eg, vs. *50% on days 10-12 of Keller [3] ; see Supplementary Video S1 and S2). On days 16-18, *100% of hEBs were beating and, for the cTnT-positive cells, about 17% were Ki67-positive proliferating (Supplementary Fig. S1 ).
As anticipated, using real-time RT-PCR analysis, we detected that the transcript expression of the pluripotency markers OCT4 and Nanog decreased time dependently, and rapidly became undetectable by days 4-5 (Fig. 2 ). By contrast, the transcript expression of T-box factor Brachyury (T) and helix-loop-helix transcription factor mesoderm posterior 1 (MESP1), one of the earliest ''cardiac'' mesoderm markers, transiently spiked during days 2-5 upon the addition of BMP4 and activin-A. During the same time interval, the cardiac progenitor marker Isl1 as well as the transcription factors GATA4 and Hand1, critical for early cardiac differentiation, also became expressed, with the early cardiac progenitor marker Nkx2.5 appearing shortly after on d5 (after IWR addition), peaked at day 8, and continued to remain high beyond day 14. Consistent with a successful cardiac differentiation, further analyses revealed that transcripts of sarcomeric proteins, such as MYH6, MYH7, cTnT, and NPPA, that are signatures of contractile CMs also had similar timedependent expression patterns. Expression levels of ML2Cv, a marker of mature ventricular CMs, increased to a high level at day 16 and remained so over 30 days. By contrast, the expression of MLC2a, which is normally expressed in atrial and immature ventricular CMs, peaked at day 16 and declined afterward. The temporal transcript expression profiles of the various pluripotency, mesodermal, and cardiac makers are summarized in Figure 2 .
hESC-CMs displayed a time-dependent switch from MLC2a to MLC2v positive
To quantitate the efficiency of our specification protocol, flow cytometry analysis was performed on differentiated HES2 cells collected at days [16] [17] [18] . As depicted in Figure  3A , the yield of cTnT + cells was 90.8% for the representative reaction shown with an average of 87% -3.4% for the HES2 line (n = 6 independent reactions; Fig. 3B ). Immunostaining experiments confirmed the subcellular expression of cardiac-specific proteins (ie, MLC2v, MLC2a, MF20, a-actinin, and connexin 43) with the expected sarcomeric structures (Fig. 4A) , indicating that the derived cells were hESC-CMs. As shown in Figure 4B , by day 20, *85% of the differentiated cells were positively stained for ML2Cv. Consistent with our qRT-PCR data, only *35% of the MLC2v-positive cells were also positive for MLC2a (Fig. 4B) . By day 40, essentially all of HES2-VCMs did not express MLC2a but only MLC2v (Fig. 4C) , signifying that the VCMs derived were amenable to maturation in vitro. Considering the input of 300,000 hESCs at day 4, the output 4 WENG ET AL.
of our protocol as determined by flow cytometry was *32-72 cTnT-positive cells per HES2 cell at day 14.
Functional characterization of hESC-VCMs
To confirm the functionality as well as chamber-specific identity of our derived CMs, we next performed patchclamp recordings and Ca 2 + imaging on 35-50-day-old single cells isolated from cardiogenic EBs for examining their electrophysiological profiles. Of the 42 HES2-CMs recorded (from five independent batches), 93% displayed an AP profile that was most consistent with the immature ventricular type that we had previously published [17, 21, 26] (Fig. 5A, D) . Immature traits such as spontaneous AP firing, a depolarized resting membrane potential or maximum diastolic potential, and phase 4 depolarization were readily observed. AP parameters are summarized in Table 1 . Consistent with AP data, when unselected cells isolated from HES2-EBs were immunostained with MLC2v and cTnT, > 80% of the cells were doubly MLC2v and cTnT positive, suggesting that our method supports a high percentage of VCM differentiation (Fig. 5B) . After zeocin selection, 100% of LV-MLC2v-Tdtomato-T2A-zeocin-transduced cells displayed typical ventricular-like APs. Therefore, the cells derived by our protocol were functional hESC-VCMs. As for Ca 2 + handling, Figure 5C shows that transients from these cells had amplitudes and kinetics smaller and slower than those of adults as we previously reported [27, 28] . Further, caffeine-induced Ca 2 + was also observed, indicating a functional sarcoplasmic reticulum. Upon isoproterenol (Iso) application to our hESC-VCMs, a positive chronotropic response with increased spontaneous AP and Ca 2 + transient firings was observed. However, the transient amplitude remained unchanged (P > 0.05), indicating a null ionotropic response to b-adrenergic stimulation. Moreover, a live recording of the electrically induced Ca 2 + transient
FIG. 2.
Quantitative PCRbased gene expression analysis of embryoid bodies (EBs) at different stages of cardiac differentiation. HES2 were subjected to the cardiac differentiation protocol described in Figure 1 . Expression levels of pluripotent, cardiac mesoderm markers, and cardiac specific genes were normalized and expressed relative to housekeeping gene GAPDH. Plots shown are representative of three independent experiments.
VENTRICULAR CARDIOMYOCYTES FROM PLURIPOTENT STEM CELLS
(Supplementary Video S3) recorded from a culture of iPSC-CM also indicated the functional Ca 2 + handling in the CMs. When switched to the voltage-clamp mode, signature ventricular ionic currents, such as voltage-dependent I Na , L-type I Ca , I Kr , sarcolemmal I KATP , could be recorded (Fig. 6) , electrophysiologically confirming the identity as VCMs.
Immature mitochondrial structure of HES2-VCMs
Others have reported that the structure of mitochondria reflects various stages of cardiogenesis [29, 30] . At day 30 post-differentiation, similar to embryonic/fetal CMs, HES2-VCMs displayed a perinuclear mitochondrial structure, as shown by staining with the mitochondrial COXIV-specific antibody (Fig. 7A) . In addition, the mitochondrial volume of HES2-VCMs was 33.7% -0.4% (n = 16) at day 30, smaller than the reported value of 40% in human adult CMs [31] .
Therefore, HES2-VCMs were more comparable to fetal CMs that also carry a lower mitochondrial mass with perinuclear localization compared with adult CMs [32] . We next examined the mitochondrial inner membrane potential of HES2-VCMs using the potential-sensitive JC-1 dye. Figure  7B shows the appearance of both green and red fluorescence HES2-VCMs, demonstrating the presence of both depolarized (green monomer) and hyperpolarized (orange aggregate) mitochondrial membrane potential. Areas of depolarized mitochondrial membrane potential were found in the perinuclear region while areas of hyperpolarized potential were mainly found at the perimeter of HES2-VCMs. Similar to primary CMs, when subjected to oxidative stress in the form of H 2 O 2 , hESC-VCMs showed a depolarization of their mitochondrial membrane potential (increase in green vs. orange fluorescence) with JC-1 orange/green intensity ratio decreased from 1.146 to 0.410. Given that most methods for directed cardiac differentiation reported to date require line-dependent optimizations of growth factors [1, 3, 4, 15] , we next tested the versatility of our protocol for consistent hPSC-VCM yields with different lines. Indeed, we have previously reported that distinct hESC lines have different cardiogenic potentials [33] . Such differences can be further exemplified in hiPSCs, which are known to display significant line-to-line and clone-to-clone variability. Therefore, we generated hiPSCs from adult peripheral blood CD34
+ cells using non-viral episomal vectors (see Materials and Methods section). All our tested hiPSC lines retained a normal karyotype, stained positively for pluripotency markers by immunocytochemistry, and expressed high levels of Oct4 and Rex1 (data not shown). Differentiation into three germ layers was confirmed by qRT-PCR and immunostaining. When injected subcutaneously into the immunodeficient mice, all tested hiPSC lines formed teratomas consisting of the three primitive germ layers (Supplementary Fig. S2 ). When these hiPSC lines were subjected to ventricular specification by our protocols, spontaneously contracting cardiogenic EBs routinely emerged on days 8-9 and achieved *80% cTnT + cells (Fig. 3) , which likewise expressed the cardiac markers cTnT, aactinin, and MLC2a with immature signature ventricular AP and Ca 2 + transients (Fig. 5 ). When tested with additional hESC lines, H7 and H9 DF , qualitatively similar data in terms of time when beating EBs first appeared, % of cTnT + cells, APs, and Ca 2 + transients were also consistently observed (Figs. 3 and 5) . Taken collectively, the yield of VCMs ranged 92%-100% as gauged by APs (Fig. 5G) . The remainders were atrail-like hPSC-CMs (Fig. 5A) . We did not detect any nodal-like hPSC-CMs. 
Transplantation of hPSC-VCMs for in vivo studies
Previous transplantation studies of hESC-CMs almost always involved cell mixtures with low yields of hESC-CMs or heterogenous mixtures of V and other chamber-specific types [24, 34] . To test the in vivo survival of our hPSCVCMs, we employed our protocol to differentiate a H9 cell line expressing the double-fusion GFP-luciferase proteins to H9-VCMs [24] . Figure 8A shows that > 72% of cTnT + cells could be generated. After transplantation into the kidney capsule of immunodeficient mice, cTnT + cells remained detected for least 27 days (Fig. 8B, C) . Immunohistochemistry staining showed a localized region of cTnT-positive cells in the transplanted kidney capsule (Fig. 8D) . Therefore, our robust differentiation of VCMs of hPSCs provides a great cell source for future transplantation experiments.
Discussion
In the present study, we have made the following salient accomplishments: (i) a final output of *35-70 hPSCVCMs per hPSC (vs. 1-20 hPSC-CMs per hPSC, of which merely a fraction was VCMs); (ii) a relatively simple and cost-effective protocol that reproducibly generates cardiac cells within a short time and requires the least amounts of reagents (eg, bFGF and VEGF were not needed for expansion); (iii) the protocol is effective for multiple hESC and hiPSC lines without the need of line-dependent optimization; and (iv) ventricular specification of hESC/iPSCs, as confirmed electrophysiologically by ventricular AP and ionic currents. These results are further discussed in the following headings in relation other recent relevant studies.
Comparison with other directed cardiac differentiation protocols
Recent advances in directed cardiac differentiation protocols have enabled the derivation of hESC/iPSC-CMs in larger quantities. These protocols have generally adopted the approach of sequential addition of growth factors. The first major breakthrough was accomplished by Yang et al. summary of averaged current densities under the same conditions. Cells were stimulated to 0 mV for 1,000 ms from a holding potential of -80 mV preceded by a 100-ms prepulse to -10 mV (n = 5). **P < 0.01 compared with control group; ## P < 0.01 compared with CN group. Color images available online at www.liebertpub.com/scd who developed a directed differentiation protocol of deriving hESC (HES2)-CMs via stage-specific addition of a combination of activin-A, BMP4, FGF2, VEGF, and Dickkopf-1 (DKK-1) to generate a tripotent cardiovascular progenitor population [3] . The method requires optimization on the growth factor concentrations for different specific PSC lines with the reported yield of > 50% of beating clusters. Using this protocol, we could differentiate *40% of cTnT + cells from HES2 cells, which heterogeneously consisted of a mixture of ventricular, atrial, and pacemaker derivatives (with a ratio of 42:53:5) [26] . The total output is therefore *4 hPSC-CMs or 2.2 hPSC-VCMs per hPSC.
Burridge et al. optimized > 45 experimental variables to develop a protocol with optimized concentrations of BMP4 and FGF2, polyvinyl alcohol, serum, and insulin for cardiac differentiation of hESCs (H1 and H9) and hiPSC lines derived from neonatal CD34 + CBs (CBiPSC6.2 and CBiPSC6.11) and adult fibroblasts (iPS-IMR90-1) using nonintegrated episomal plasmids to generate 64%-89% cTnT + cells by day 9 [4] . The derived CMs are functionally responsive to cardioactive drugs when optically mapped as multicellular clusters. However, the efficiency and AP profiles and distribution of the differentiated CMs were not mentioned.
In the study by Lian et al., the investigators employ glycogen synthase kinase 3 (GSK3) inhibitors combined with the b-catenin shRNA or a chemical Wnt inhibitor to produce a 80%-98% purity of functional CMs in 14 days from hESCs (H9, H13, and H14) and multiple hiPSC lines (6-9-9, 19-9-11, and IMR90C4) [12] . Similar to our findings reported here, beating clusters are observed between days 8 and 10. About 20% of day-20 CMs are proliferative as indicated by Ki67 staining or BrdU assay. The number of cells generated by this protocol is 15 CMs per hPSC input without any enrichment and/or purification step. The method focuses on early induction of canonical Wnt signaling and suppression of canonical Wnt signaling at later stages of differentiation to synergistically enhance the CM yield.
Zhang et al. reported a matrix sandwich method by overlaying monolayer-cultured hPSCs with Matrigel [2] . They combined the matrix sandwich with sequential application of activin-A, BMP4, and bFGF to generate a high purity of up to 98% and a yield of up to 11 CMs/input PSC from multiple PSC lines, including H1, H9, and three iPSC lines derived from foreskin fibroblasts using nonintegrating vectors and the lentiviral-generated iPS cell line IMR90 clone 4 (IMR90 C4). Atrial/ventricular distribution is not reported.
Ren et al. reported early modulation of the BMP4 coupled with late inhibition of Wnt signaling pathways in hiPSCs to generate high efficiency of cardiac differentiation [14] . This method, tested on H7 only, requires a high concentration of serum (20%) but with a relatively low percentage of cTNTpositive cells (*16%). AP profile is also not reported. Minami et al. reported the use of a single small-molecule KY02111 to promote hPSC differentiation into CMs with a yield of up to 98% by inhibiting WNT signaling [13] . EP data show that VCMs and pacemaker cells are present and electrophysiologically functional. The method, tested on four hiPSC lines, can be achieved in a serum-and xeno-free condition to produce *4.2 · 10 6 hPSC-CMs from *6 to · 10 6 seeded initially per well or 0.7 hPSC-CMs per hPSC. Given that this method requires only a single small molecule to direct CM differentiation, it is by far the simplest protocol. The ventricular yield is unknown.
Comparison with our recent ventricular specification protocol
The present method differs from our recently published protocol [35] in several ways. First, here we used ROCK and Matrigel instead of Blebbistatin on day 0. Second, 10-fold less of BMP4 was used on day 0 and 2.5-fold less of activin-A was added on day 1 in our protocol. Third, our cells were digested by Accutase into single cells on day 0, as opposed to small clusters in the other protocol. Fourth, there was no media change on day 3, instead of changing to StemPro + AA with IWR on day 4. Fifth, IWR-1 was added on day 4 at 5 mM, instead of 2.5 mM on day 4.5. Finally, our cells were maintained in normoxia and differentiated in hypoxia between days 0 and 8 (vs. maintenance of undifferentiated cells under hypoxia but differentiation under normoxic condition, ie, the exact opposite). Collectively, while the purity and % of PSC-VCMs are comparable, the present yield and efficiency were higher. Although we previously did not report the efficiency, the present protocol provides *5 · more cTNT-positive or PSC-VCMs per PSC. Assuming 300,000 hESCs on day 4, the new protocol generates up to 72 cTNT-positive cells per HES2 cell (vs. 13 cTnT-positive cells per undifferentiated cell). We have now also expanded to include additional lines.
Conclusion
Recent differentiation methods have led to higher CM yields compared to traditional spontaneous differentiation protocols. However, many require optimization of multiple growth factors for different hPSC lines, with variability often seen with hiPSC lines. Our method does not require an optimization between activin-A and BMP4; the same concentrations of activin-A and BMP4 were used for all the different hESC and hiPSC lines tested but both the efficiency for ventricular specification remains consistently high. Further, most data are reported as the percentage of contracting EBs. Since EBs contain non-CMs and singlecell assays were not performed, the ventricular yields are not known. Further, the percent yield of ventricular CMs compared with other chamber-specific types is often not reported. In sum, our protocol reported here represents a cost-effective, reproducible, and straightforward VCM specification method for hESC and hiPSC lines. These results may lead to mass production of hPSC-VCMs on a suitable scalable platform (eg, bioreactors and microcarriers).
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